StageSeed VC | Alive
Infinitesima specializes in advanced metrology solutions for the semiconductor industry. It develops the Metron3D, a HVM-ready metrology system for the high-speed measurement of challenging nanoscale structures that are critical to modern semiconductor manufacturing, and the Rapid Probe Microscope (RPM Scanner), a module for integration into either a host tool for operation in both an air or vacuum environment or for integration into a dedicated, stand-alone platform. The company also offers scanning probe microscopy services. Infinitesima serves semiconductor equipment companies and semiconductor manufacturers. It was founded in 2001 and is based in Oxfordshire, England.
Missing: Infinitesima's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Infinitesima's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Infinitesima has filed 29 patents.
The 3 most popular patent topics include:
- Scanning probe microscopy
Scanning probe microscopy, Nanotechnology, Microscopy, Spectroscopy, Electron microscopy
Scanning probe microscopy, Nanotechnology, Microscopy, Spectroscopy, Electron microscopy
Latest Infinitesima News
Aug 23, 2022
Infinitesima’s revolutionary Metron3D metrology system enables in-line 3D process control for next generation semiconductors ABINGDON, United Kingdom, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Infinitesima is pleased to announce the completion of its investment round to ramp production of the Metron3D 300 mm in-line wafer metrology system in support of customer shipments starting from Q4 2022. The Metron 3D system features the company’s proven Rapid Probe Microscope (RPM) technology together with modules from leading industry suppliers to enable maximum performance and reliability. The system has been designed for high throughput, fully automated, in-line production process control to address the increasing need for high resolution 3D metrology in advanced semiconductor processes. “We are excited that our unique high-speed probe technology, together with the growing industry need for in-line 3D metrology, has resulted in strong customer engagements,” said Professor Andrew Humphris, CTO and founder of Infinitesima. The investment round was led by Wonik Investment Partners , a subsidiary of the leading international Korean company Wonik, which operates a broad range of businesses, including semiconductor materials and equipment. Dong Su Kim, President of Wonik Investment Partners, commented, “We recognise the significant growth opportunity for Infinitesima, with its unique 3D metrology technology and experienced team that can address the increasingly challenging requirements for process control of next generation semiconductors.” Andrew Dixon, Infinitesima Chairman and founder of ARC InterCapital , said, “We are delighted to welcome Wonik Investment Partners as a co-investor and partner as we introduce the Metron3D at leading semiconductor manufacturers.” About Infinitesima Infinitesima Limited is a UK based leader in advanced metrology solutions for the semiconductor industry. The company has pioneered an innovative technology combining the 3-dimensional surface detection capability of atomic force microscopy, with high-speed laser activation, and the accuracy of interferometry, the Rapid Probe Microscope (RPM), protected by an extensive patent portfolio. The company’s RPM technology has been integrated as a module by leading semiconductor equipment companies and is in use at leading semiconductor manufacturers. Semiconductor manufacturers increasingly require higher resolution 3D metrology solutions to control next generation processes that cannot be addressed by current optical and electron beam techniques. Infinitesima has introduced a high-speed metrology system, Metron3D, featuring the company’s patented RPM technology, to address the growing customer need for in-line sub-nanometer* 3D process control. * 1 nanometer (nm) is 10-9 of a meter (a single silicon atom is ~0.2nm in diameter). A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e2690301-9698-4cf8-a3bd-bb69d9c609ca Attachments
Infinitesima Frequently Asked Questions (FAQ)
When was Infinitesima founded?
Infinitesima was founded in 2001.
Where is Infinitesima's headquarters?
Infinitesima's headquarters is located at Suite 1, Hitching Court, Abingdon Business Park, Abingdon, Oxfordshire.
What is Infinitesima's latest funding round?
Infinitesima's latest funding round is Seed VC.
Who are the investors of Infinitesima?
Investors of Infinitesima include WONIK Investment Partners, University of Bristol and Sussex Place Ventures.
Who are Infinitesima's competitors?
Competitors of Infinitesima include EUV Tech and 4 more.
Compare Infinitesima to Competitors
The COMET Group is a manufacturer of systems and components for the growth markets of non-destructive testing, security and semiconductors. Since acquiring the YXLON group in July 2007, COMET has been the global market leader in non-destructive testing and examination using X-Ray technology. Based on the core competencies of vacuum technology, high voltage engineering and materials science, as well as the core products of X-Ray tubes and vacuum capacitors, the COMET Group supplies a and highly flexible range of components, modules, systems and services from a single source. COMET and YXLON have operated in the market for X-Ray-based non-destructive testing for decades and their operations represent dedicated divisions within the COMET Group. While COMET primarily manufactures high-tech components and modules, YXLON offers system solutions, including software and services. The major markets are the automotive, aerospace, pipeline and electronics industries, as well as security at airports and borders. In addition, COMET's Vacuum Capacitors business develops and manufactures customized components and modules for systems used in semiconductor fabrication. End products, aside from memory chips, include flat panel displays and solar panels. Vacuum capacitors are also used for frequency stabilization in radio transmitters. Today, the COMET Group is represented in all world markets, manufactures in Switzerland, Germany and Denmark, and maintains subsidiaries in the USA, China and Japan.The business activities are reflected in divisions for OEM and end customer business. Employees' educational level is exceptionally high; nearly 90% are trained specialists, a third of whom hold degrees from universities or polytechnics. About 10% of sales is invested in research and development, ensuring a sustained high rate of innovation. The COMET Group's culture is customer-oriented throughout. Commitment, respect and transparency characterize the company and its relations with stakeholders. The company's aspiration to be aims to drive everything the company do.
Real Imaging is developing an imaging solution for breast cancer detection which is both accurate and patient-friendly. Real imaging's MIRA technology will increase correct detection rates and decrease the amount of false diagnoses for women of all ages around the globe.
Micrima develops a system to improve the detection of breast cancer. The imaging system captures three-dimensional (3D) images through the use of harmless radio waves. The safe, low-cost system enables women of all ages to be screened for breast cancer in GP surgeries, or alternative high street locations, with results that are now comparable with traditional X-ray mammograms. It was founded in 2006 and is based in Bristol, United Kingdom.
Stage I Diagnostics is a cancer biotechnology company focused on providing early stage diagnosis provided by new biomarkers deployed through In-Vitro Diagnostics (IVD). The company's initial focus is the early diagnosis of ovarian cancer. Stage I's core competency is the process of converting newly discovered genes into commercial products which impact clinical decisions. The company's approach is to determine what characteristics new biomarkers should have to achieve the best diagnostic results in targeted diseases and then to discover what genes exist that fit those characteristics. This process has led us to not only discover and patent numerous genes associated with various types of cancer but also clone 4 new genes.
Orison Corporation was founded to design, manufacture and market a ultrasound technology platform for early breast cancer detection and diagnosis. Orison's technology aims to utilize Full Field Digital Ultrasound (FDDU) as an enabler that aims to allow the radiologist, for a time, to view breast tissue in a three dimensional environment. The outcome is earlier detection of breast cancer prior to metastasis, resulting in greater five-year survival rates and decreased treatment costs.
Microwave Imaging Systems Technology was founded in 1995 by Dr. Keith Paulsen and Dr. Paul Meaney of the Thayer School of Engineering and has developed a microwave-based, breast imaging system which aims to provide high-contrast images for breast cancer diagnostics. Per the company, the NIH has invested more than $6 million to develop and demonstrate the MIST system for tumor imaging. The company reports that testing on more than 150 patients has shown excellent detection of breast tumors.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.